Summary
17.01 0.06(0.32%)10/04/2024
Integra Lifesciences Holdings Corp (IART)
Integra Lifesciences Holdings Corp (IART)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 0.35 | -5.11 | -12.16 | -41.04 | -49.70 | -54.70 | -71.71 | 267.68 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 17.01 | |
| Open | 17.21 | |
| High | 17.47 | |
| Low | 16.96 | |
| Volume | 527,899 | |
| Change | 0.06 | |
| Change % | 0.35 | |
| Avg Volume (20 Days) | 646,621 | |
| Volume/Avg Volume (20 Days) Ratio | 0.82 | |
| 52 Week Range | 16.81 - 45.42 | |
| Price vs 52 Week High | -62.56% | |
| Price vs 52 Week Low | 1.16% | |
| Range | -1.19 | |
| Gap Up/Down | -0.01 | |
Fundamentals | ||
| Market Capitalization (Mln) | 1,355 | |
| EBIDTA | 362,599,008 | |
| PE Ratio | 50.9608 | |
| PEG Ratio | 0.8283 | |
| WallStreet Target Price | 33.63 | |
| Book Value | 20.2920 | |
| Earnings Per Share | 0.5100 | |
| EPS Estimate Current Quarter | 0.5500 | |
| EPS Estimate Next Quarter | 0.7500 | |
| EPS Estimate Current Year | 3.0700 | |
| EPS Estimate Next Year | 3.3700 | |
| Diluted EPS (TTM) | 0.5100 | |
| Revenues | ||
| Profit Marging | 0.0263 | |
| Operating Marging (TTM) | 0.1098 | |
| Return on asset (TTM) | 0.0383 | |
| Return on equity (TTM) | 0.0246 | |
| Revenue TTM | 1,529,598,976 | |
| Revenue per share TTM | 19.3490 | |
| Quarterly Revenue Growth (YOY) | -0.0310 | |
| Quarterly Earnings Growth (YOY) | -0.6010 | |
| Gross Profit (TTM) | 982,033,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 50.9608 | |
| Forward PE | 9.9404 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.6236 | |
| Revenue Enterprise Value | 2.5628 | |
| EBITDA Enterprise Value | 15.4351 | |
| Shares | ||
| Shares Outstanding | 78,799,696 | |
| Shares Float | 67,746,461 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.04 | |
| Insider (%) | 13.78 | |
| Institutions (%) | 89.21 | |
10/04 10:05 EST - zacks.com
Here's Why You Should Hold IART Stock in Your Portfolio Now
Integra's strong growth in the Tissue Technologies and CSS business segment bolsters investors' confidence in the stock.
Here's Why You Should Hold IART Stock in Your Portfolio Now
Integra's strong growth in the Tissue Technologies and CSS business segment bolsters investors' confidence in the stock.
09/04 16:01 EST - globenewswire.com
Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference
PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the Morgan Stanley Healthcare conference on September 6, 2024 at 10:45am ET.
Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference
PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the Morgan Stanley Healthcare conference on September 6, 2024 at 10:45am ET.
09/04 10:32 EST - globenewswire.com
Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference
PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer, will present at the Wells Fargo Healthcare conference on September 4, 2024 at 1:30pm ET.
Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference
PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer, will present at the Wells Fargo Healthcare conference on September 4, 2024 at 1:30pm ET.
08/21 16:15 EST - globenewswire.com
Integra LifeSciences Continues to Make Progress on Its ESG Strategy
The company published its third ESG report, underscoring its values and commitment to restoring lives The company published its third ESG report, underscoring its values and commitment to restoring lives
Integra LifeSciences Continues to Make Progress on Its ESG Strategy
The company published its third ESG report, underscoring its values and commitment to restoring lives The company published its third ESG report, underscoring its values and commitment to restoring lives
07/30 13:51 EST - zacks.com
Integra's (IART) Q2 Earnings and Revenues Top, Margins Down
Integra's (IART) second-quarter 2024 results reflect strong demand for its diverse portfolio of leading brands and the continued successful market adoption of CereLink.
Integra's (IART) Q2 Earnings and Revenues Top, Margins Down
Integra's (IART) second-quarter 2024 results reflect strong demand for its diverse portfolio of leading brands and the continued successful market adoption of CereLink.
07/30 11:36 EST - benzinga.com
Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results
Integra LifeSciences IART reported upbeat second-quarter earnings and lowered its FY24 guidance below estimates on Monday.
Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results
Integra LifeSciences IART reported upbeat second-quarter earnings and lowered its FY24 guidance below estimates on Monday.
07/29 12:23 EST - fool.com
Why Integra Lifesciences Stock Is Sinking Today
Integra Lifesciences topped analysts' Q2 revenue and earnings estimates. However, the company reduced its full-year guidance.
Why Integra Lifesciences Stock Is Sinking Today
Integra Lifesciences topped analysts' Q2 revenue and earnings estimates. However, the company reduced its full-year guidance.
07/29 10:31 EST - zacks.com
Compared to Estimates, Integra (IART) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Compared to Estimates, Integra (IART) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
07/29 08:24 EST - benzinga.com
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Monday.
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Monday.
07/29 08:16 EST - zacks.com
Integra LifeSciences (IART) Q2 Earnings and Revenues Surpass Estimates
Integra LifeSciences (IART) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.71 per share a year ago.
Integra LifeSciences (IART) Q2 Earnings and Revenues Surpass Estimates
Integra LifeSciences (IART) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.71 per share a year ago.
07/29 06:00 EST - globenewswire.com
Integra LifeSciences Reports Second Quarter 2024 Financial Results
PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2024.
Integra LifeSciences Reports Second Quarter 2024 Financial Results
PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2024.
07/27 09:00 EST - investorplace.com
The 3 Best Brain-Computer Interface Stocks to Buy Now
Brain-computer interface (BCI) technology creates a direct link between the brain's electrical activity and a digital device. This connection can bring a vast range of benefits in assisting, augmenting and repairing human cognitive functions.
The 3 Best Brain-Computer Interface Stocks to Buy Now
Brain-computer interface (BCI) technology creates a direct link between the brain's electrical activity and a digital device. This connection can bring a vast range of benefits in assisting, augmenting and repairing human cognitive functions.
07/22 11:06 EST - zacks.com
Earnings Preview: Integra LifeSciences (IART) Q2 Earnings Expected to Decline
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Integra LifeSciences (IART) Q2 Earnings Expected to Decline
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
07/16 10:15 EST - zacks.com
Integra's (IART) New Site to Produce Recalled Tissue Products
Integra (IART) is set to recommence the manufacturing of PriMatrix and SurgiMend at its new facility in Braintree, MA.
Integra's (IART) New Site to Produce Recalled Tissue Products
Integra (IART) is set to recommence the manufacturing of PriMatrix and SurgiMend at its new facility in Braintree, MA.
07/15 08:00 EST - globenewswire.com
Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts
The company plans on operationalizing this new state-of-the-art facility in the first half of 2026 The company plans on operationalizing this new state-of-the-art facility in the first half of 2026
Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts
The company plans on operationalizing this new state-of-the-art facility in the first half of 2026 The company plans on operationalizing this new state-of-the-art facility in the first half of 2026
06/05 12:35 EST - zacks.com
Why Is Integra (IART) Up 26% Since Last Earnings Report?
Integra (IART) reported earnings 30 days ago. What's next for the stock?
Why Is Integra (IART) Up 26% Since Last Earnings Report?
Integra (IART) reported earnings 30 days ago. What's next for the stock?
05/30 18:40 EST - zacks.com
Is The Options Market Predicting A Spike In Integra LifeScience (IART) Stock?
Investors need to pay close attention to Integra LifeScience (IART) stock based on the movements in the options market lately.
Is The Options Market Predicting A Spike In Integra LifeScience (IART) Stock?
Investors need to pay close attention to Integra LifeScience (IART) stock based on the movements in the options market lately.
05/13 16:30 EST - globenewswire.com
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
PRINCETON, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2024 Bank of America Healthcare conference on Tuesday, May 14, 2024 at 4:40pm ET.
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
PRINCETON, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2024 Bank of America Healthcare conference on Tuesday, May 14, 2024 at 4:40pm ET.
05/13 13:10 EST - zacks.com
Deciphering Integra (IART) International Revenue Trends
Examine the evolution of Integra's (IART) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Deciphering Integra (IART) International Revenue Trends
Examine the evolution of Integra's (IART) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
05/07 12:36 EST - zacks.com
Integra's (IART) Q1 Earnings Match Estimates, Margins Down
Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.
Integra's (IART) Q1 Earnings Match Estimates, Margins Down
Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.